These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 26821052)

  • 21. The role of free-fatty acid receptor-4 (FFA4) in human cancers and cancer cell lines.
    Senatorov IS; Moniri NH
    Biochem Pharmacol; 2018 Apr; 150():170-180. PubMed ID: 29452095
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Signal transduction responses to lysophosphatidic acid and sphingosine 1-phosphate in human prostate cancer cells.
    Gibbs TC; Rubio MV; Zhang Z; Xie Y; Kipp KR; Meier KE
    Prostate; 2009 Oct; 69(14):1493-506. PubMed ID: 19536794
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Receptor tyrosine kinase activation induces free fatty acid 4 receptor phosphorylation, β-arrestin interaction, and internalization.
    Villegas-Comonfort S; Guzmán-Silva A; Romero-Ávila MT; Takei Y; Tsujimoto G; Hirasawa A; García-Sáinz JA
    Eur J Pharmacol; 2019 Jul; 855():267-275. PubMed ID: 31078517
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cross-talk between lysophosphatidic acid receptor 1 and tropomyosin receptor kinase A promotes lung epithelial cell migration.
    Nan L; Wei J; Jacko AM; Culley MK; Zhao J; Natarajan V; Ma H; Zhao Y
    Biochim Biophys Acta; 2016 Feb; 1863(2):229-35. PubMed ID: 26597701
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lysophosphatidic acid decreases epidermal growth factor receptor binding in airway epithelial cells.
    Kassel KM; Schulte NA; Parker SM; Lanik AD; Toews ML
    J Pharmacol Exp Ther; 2007 Oct; 323(1):109-18. PubMed ID: 17640953
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Characterization of epidermal growth factor receptor function in lysophosphatidic acid signaling in PC12 cells.
    Kim SN; Park JG; Lee EB; Kim SS; Yoo YS
    J Cell Biochem; 2000 Jan; 76(3):386-93. PubMed ID: 10649436
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Transactivation of the epidermal growth factor receptor mediates parathyroid hormone and prostaglandin F2 alpha-stimulated mitogen-activated protein kinase activation in cultured transgenic murine osteoblasts.
    Ahmed I; Gesty-Palmer D; Drezner MK; Luttrell LM
    Mol Endocrinol; 2003 Aug; 17(8):1607-21. PubMed ID: 12738761
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Estrogen-induced activation of Erk-1 and Erk-2 requires the G protein-coupled receptor homolog, GPR30, and occurs via trans-activation of the epidermal growth factor receptor through release of HB-EGF.
    Filardo EJ; Quinn JA; Bland KI; Frackelton AR
    Mol Endocrinol; 2000 Oct; 14(10):1649-60. PubMed ID: 11043579
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lysophosphatidic acid-regulated mitogenic ERK signaling in androgen-insensitive prostate cancer PC-3 cells.
    Kue PF; Taub JS; Harrington LB; Polakiewicz RD; Ullrich A; Daaka Y
    Int J Cancer; 2002 Dec; 102(6):572-9. PubMed ID: 12447997
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Role for CCN1 in lysophosphatidic acid response in PC-3 human prostate cancer cells.
    Balijepalli P; Knode BK; Nahulu SA; Abrahamson EL; Nivison MP; Meier KE
    J Cell Commun Signal; 2024 Mar; 18(1):e12019. PubMed ID: 38545253
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Lysophosphatidic acid-induced ERK activation and chemotaxis in MC3T3-E1 preosteoblasts are independent of EGF receptor transactivation.
    Karagiosis SA; Chrisler WB; Bollinger N; Karin NJ
    J Cell Physiol; 2009 Jun; 219(3):716-23. PubMed ID: 19189345
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lysophosphatidic acid regulates murine blastocyst development by transactivation of receptors for heparin-binding EGF-like growth factor.
    Liu Z; Armant DR
    Exp Cell Res; 2004 Jun; 296(2):317-26. PubMed ID: 15149861
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Essential role for G proteins in prostate cancer cell growth and signaling.
    Kue PF; Daaka Y
    J Urol; 2000 Dec; 164(6):2162-7. PubMed ID: 11061948
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Lysophosphatidic acid-induced squamous cell carcinoma cell proliferation and motility involves epidermal growth factor receptor signal transactivation.
    Gschwind A; Prenzel N; Ullrich A
    Cancer Res; 2002 Nov; 62(21):6329-36. PubMed ID: 12414665
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Activity of dietary fatty acids on FFA1 and FFA4 and characterisation of pinolenic acid as a dual FFA1/FFA4 agonist with potential effect against metabolic diseases.
    Christiansen E; Watterson KR; Stocker CJ; Sokol E; Jenkins L; Simon K; Grundmann M; Petersen RK; Wargent ET; Hudson BD; Kostenis E; Ejsing CS; Cawthorne MA; Milligan G; Ulven T
    Br J Nutr; 2015 Jun; 113(11):1677-88. PubMed ID: 25916176
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Free-fatty acid receptor-1 (FFA1/GPR40) promotes papillary RCC proliferation and tumor growth via Src/PI3K/AKT/NF-κB but suppresses migration by inhibition of EGFR, ERK1/2, STAT3 and EMT.
    Karmokar PF; Moniri NH
    Cancer Cell Int; 2023 Jun; 23(1):126. PubMed ID: 37355607
    [TBL] [Abstract][Full Text] [Related]  

  • 37. LPA1 receptors mediate stimulation, whereas LPA2 receptors mediate inhibition, of migration of pancreatic cancer cells in response to lysophosphatidic acid and malignant ascites.
    Komachi M; Tomura H; Malchinkhuu E; Tobo M; Mogi C; Yamada T; Kimura T; Kuwabara A; Ohta H; Im DS; Kurose H; Takeyoshi I; Sato K; Okajima F
    Carcinogenesis; 2009 Mar; 30(3):457-65. PubMed ID: 19129242
    [TBL] [Abstract][Full Text] [Related]  

  • 38. From outside to inside and back again: the lysophosphatidic acid-CCN axis in signal transduction.
    Balijepalli P; Meier KE
    J Cell Commun Signal; 2023 Sep; 17(3):845-849. PubMed ID: 36795277
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inhibition of breast cancer cell growth in vitro by a tyrosine kinase inhibitor.
    Reddy KB; Mangold GL; Tandon AK; Yoneda T; Mundy GR; Zilberstein A; Osborne CK
    Cancer Res; 1992 Jul; 52(13):3636-41. PubMed ID: 1617636
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Lysophospholipids activate ovarian and breast cancer cells.
    Xu Y; Fang XJ; Casey G; Mills GB
    Biochem J; 1995 Aug; 309 ( Pt 3)(Pt 3):933-40. PubMed ID: 7639713
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.